Medifirst Solutions Announces Agreement With Life Science Quest

Medifirst Solutions Inc., a provider of innovative laser technology with its U.S. Food and Drug Administration (FDA) 510(k)-cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, has signed an agreement with Life Science Quest LLC. 
 
Life Science Quest helps businesses to promote innovative technology, unlock global market potential, and empowers their overall growth. Life Science Quest, with experience and resources across a broad spectrum of fields in healthcare and life sciences, provides high quality, results-oriented services to help businesses overcome barriers and maximize their potential.

“We are very pleased to be working with Ruobing Xia and a company of great stature, resources and outreach that believes in our Time Machine Laser technology and its potential for U.S. and global commercialization,” said Medifirst President Bruce J. Schoengood. “Life Science Quest has a vast amount of experience working in the medical and healthcare industry including an emphasis on medical devices.”
 
“We are excited to be working with Medifirst and its team to bring new solutions for pain treatment for patients in need,” said Ruobing Xia, co-founder of Life Science Quest. “We believe there is a great opportunity for the company to expand in the global medical laser market, especially in China, where we have successful experiences helping innovative companies to grow. With the rapidly developing and growing Chinese medical device and healthcare market, a population of 1.4 billion, and millions of patients suffering from acute and chronic pain, we think it’s time to introduce the Time Machine Laser as a new solution.” 
 
Xia brings a lifetime of experience to this project. As founder of Life Science Quest, Xia oversees global strategy, business development, and commercial operations. Her passion to help patients by leveraging latest science and technology, guides the focus of Life Science Quest team to bring creative solutions for innovative companies to expedite their growth and deliver better products and services. In addition, Xia is a board member of several successful startups, where she is advised on the global strategy, business development, and commercial operations.
 
Previously, Xia had a progressive career with Eli Lilly and Boehringer Ingelheim, where she managed hundred-million-dollar product launches and promotional budgets, developed sales and marketing strategies, and generated licensing deals. This was supported by her earlier career in foreign trade, international banking, finance, and venture development. Xia holds masters degrees in international affairs (finance) from Columbia University in New York, N.Y., and and MBA from IMD in Lausanne, Switzerland. 
 
Medifirst Solutions Inc., in response to its premarket notification regulatory submission for the Time Machine Series Laser, received clearance from the FDA to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Time Machine Series Lasers Model TTML-8102000 – 810/830nm is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. The hand-held laser device, with pin-point accuracy, often gives patients immediate results with no redness, swelling or down-time. This laser device offers medical professionals an affordable and effective tool to enhance their treatment protocols for their patients and provide new revenue streams for their practice. The laser division will be operated out of Medifirst’s wholly owned subsidiary, Medical Lasers Manufacturer.